Severity assessment of healthcare-associated pneumonia and pneumonia in immunosuppression

European Respiratory Journal

Volumn 40, Issue 5, 2012, Pages 1201-1210

  Carrabba, Maria ^a,b   Zarantonello, Marina ^a   Bonara, Paola ^b   Hu, Cinzia ^b   Minonzio, Francesca ^b   Cortinovis, Ivan ^a   Milani, Silvano ^a   Fabio, Giovanna ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Community acquired pneumonia; Immunocompromised patients; Severity scores

Indexed keywords

UREA;

ADULT; AGED; ARTICLE; BREATHING RATE; COMMUNITY ACQUIRED PNEUMONIA; CONFUSION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEALTH CARE ASSOCIATED PNEUMONIA; HUMAN; IMMUNE DEFICIENCY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SCORING SYSTEM; SEVERITY COMMUNITY ACQUIRED PNEUMONIA SCORING SYSTEM; SYSTOLIC BLOOD PRESSURE; TERTIARY HEALTH CARE;

AGED; AGED, 80 AND OVER; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSION; MALE; MIDDLE AGED; PNEUMONIA; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84868541446     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00187811     Document Type: Article

References (34)

1. American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171: 388-416.
2. Friedman ND, Kaye KS, Stout JE, et al. Healthcare-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002; 137: 791-797.
3. Kollef MH, Shorr A, Tabak YP, et al. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 2005; 128: 3854-3862.
4. Carratalà J, Mykietiuk A, Fernandez-Sabe N, et al. Healthcare-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes. Arch Intern Med 2007; 167: 1393-1399.
5. Micek ST, Kollef KE, Reichley RM, et al. Healthcare-associated pneumonia and community-acquired pneumonia: a single-center experience. Antimicrob Agents Chemother 2007; 51: 3568-3573.
6. Venditti M, Falcone M, Corrao S, et al. Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia. Ann Intern Med 2009; 150: 19-26.
7. Shindo Y, Sato S, Maruyama E, et al. Health-care-associated pneumonia among hospitalized patients in a Japanese community hospital. Chest 2009; 135: 633-640.
8. AnandN, Kollef MH. The alphabet soup of pneumonia: CAP, HAP, HCAP, NHAP, and VAP. Semin Respir Crit Care Med 2009; 30: 3-9.
9. Rello J, Luján M, Gallego M, et al. Why mortality is increased in healthcare-associated pneumonia: lessons from pneumococcal bacteremic pneumonia. Chest 2010; 137: 1138-1144.
10. Muder RR, Aghababian RV, Loeb MB, et al. Nursing home-acquired pneumonia: an emergency department treatment algorithm. Curr Med Res Opin 2004; 20: 1309-1320.
11. Singanayagam A, Chalmers JD, Hill AT. Severity assessment in community-acquired pneumonia. Q J Med 2009; 102: 379-388.
12. Chalmers JD, Singanayagam A, Akram AR, et al. Severity assessment tools for predicting mortality in hospitalised patients with community-acquired pneumonia. Systematic review and meta-analysis. Thorax 2010; 65: 878-883.
13. Loke YK, Kwok CS, Niruban A, et al. Value of severity scales in predicting mortality from community-acquired pneumonia: systematic review and meta-analysis. Thorax 2010; 65: 878-883.
14. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336: 243-250.
15. Lim WS, van der Eerden MM, Laing R, et al. Defining community-acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003; 58: 377-382.
16. Espana PP, Capelastegui A, Gorordo I, et al. Development and validation of a clinical prediction rule for severe community-acquired pneumonia. Am J Respir Crit Care Med 2006; 174: 1249-1256.
17. Liapikou A, Ferrer M, Polverino E, et al. Severe community-acquired pneumonia: validation of the Infectious Diseases Society of America/American Thoracic Society guidelines to predict an intensive care unit admission. Clin Infect Dis 2009; 48: 377-385.
18. Kollef KE, Reichley RM, Micek ST, et al. The modified APACHE II score outperforms CURB65 pneumonia severity score asa predictor of thirty-day mortality on methicillin resistant Staphylococcus aureus pneumonia. Chest 2008; 133: 363-369.
19. Falcone M, Corrao S, Venditti M, et al. Performance of PSI, CURB-65, and SCAP scores in predicting the outcome of patients with community-acquired and healthcare-associated pneumonia. Intern Emerg Med 2011; 6: 431-436.
20. Fang WF, Yang KJ, Wu CL, et al. Application and comparison of scoring indices to predict outcomes in patients with health care associated pneumonia. Crit Care 2011; 15: R32.
21. El-Solh AA, Alhajhusain A, Jaoude PA, et al. Validity of severity scores in hospitalized patients with nursing home-acquired pneumonia. Chest 2010; 138: 1371-1376.
22. Brito V, Niederman MS. Healthcare-associated pneumonia is a heterogeneous disease, and all patients do not need the same broad-spectrum antibiotic therapy as complex nosocomial pneumonia. Curr Opin Infect Dis 2009; 22: 316-325.
23. Ewig S, Welte T, Chastre J, et al. Rethinking the concepts of community-acquired and health-care-associated pneumonia. Lancet Infect Dis 2010; 10: 279-287.
24. Blasi F, Iori I, Bulfoni A, et al. Can CAP guideline adherence improve patient outcome in internal medicine departments? Eur Respir J 2008; 32: 902-910.
25. Park HK, Song JU, Um SW, et al. Clinical characteristics of health care-associated pneumonia in a Korean teaching hospital. Respir Med 2010; 104: 1729-1735.
26. Attridge RT, Frei CR. Health care-associated pneumonia: an evidence-based review. Am J Med 2011; 124: 689-697.
27. Zilberberg MD, Shorr AF, Micek ST, et al. Antimicrobial therapy escalation and hospital mortality among patients with HCAP: a single center experience. Chest 2008; 134: 963-968.
28. Cecere LM, Rubenfeld GD, Park DR, et al. Long-term survival after hospitalization for community-acquired and healthcare-associated pneumonia. Respiration 2010; 79: 128-136.
29. Glasmacher A, von Lilienfeld-Toal M, Schulte S, et al. An evidence-based evaluation of important aspects of empirical antibiotic therapy in febrile neutropenic patients. Clin Microbiol Infect 2005; 11: 17-23.
30. Rano A, Agusti C, Benito N, et al. Prognostic factors of non-HIV immunocompromised patients with pulmonary infiltrates. Chest 2002; 122: 253-261.
31. Arozullah AM, Parada J, Bennett CL, et al. A rapid staging system for predicting mortality from HIV-associated community-acquired pneumonia. Chest 2003; 123: 1151-1160.
32. Sanders KM, Marras TK, Chan CK. Pneumonia severity index in the immunocompromised. Can Respir J 2006; 13: 89-93.
33. Kollef MH, Morrow LE, Baughman RP, et al. Healthcare-associated pneumonia (HCAP): a critical appraisal to improve identification, management, and outcomes. Proceedings of the HCAP Summit. Clin Infect Dis 2008; 46: S296-S334.
34. Yu VL. Guidelines for hospital-acquired pneumonia and healthcare-associated pneumonia: a vulnerability, a pitfall, and a fatal flaw. Lancet Infect Dis 2011; 11: 248-252.